PRICE T ROWE ASSOCIATES INC /MD/ - SORRENTO THERAPEUTICS INC ownership

SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 232 filers reported holding SORRENTO THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.51 and the average weighting 0.0%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of SORRENTO THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$186
-99.9%
209,418
+8.4%
0.00%
Q3 2022$304,000
+6.7%
193,237
+36.5%
0.00%
Q2 2022$285,000
-6.6%
141,561
+8.3%
0.00%
Q1 2022$305,000
-41.3%
130,715
+16.8%
0.00%
Q4 2021$520,000
-33.2%
111,906
+9.7%
0.00%
Q3 2021$778,000
-35.5%
101,973
-18.1%
0.00%
Q2 2021$1,206,000
+31.9%
124,473
+12.7%
0.00%
Q1 2021$914,000
+13.1%
110,484
-6.7%
0.00%
Q4 2020$808,000
-36.5%
118,375
+3.7%
0.00%
Q3 2020$1,273,000
+179.2%
114,153
+57.4%
0.00%
Q2 2020$456,000
+225.7%
72,546
-4.8%
0.00%
Q1 2020$140,000
-6.0%
76,189
+72.4%
0.00%
Q4 2019$149,000
+77.4%
44,189
+12.4%
0.00%
Q3 2019$84,000
-17.6%
39,325
+2.5%
0.00%
Q2 2019$102,000
+61.9%
38,372
+191.3%
0.00%
Q1 2019$63,000
+103.2%
13,172
+3.1%
0.00%
Q4 2018$31,000
-90.4%
12,772
-82.6%
0.00%
Q3 2018$322,000
-8.0%
73,226
+50.8%
0.00%
Q2 2018$350,000
+52.2%
48,573
+8.7%
0.00%
Q1 2018$230,000
-21.8%
44,696
-42.2%
0.00%
Q4 2017$294,000
+14.8%
77,300
+153.8%
0.00%
Q3 2015$256,00030,4620.00%
Other shareholders
SORRENTO THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 6,000,000$66,900,0002.57%
SABBY MANAGEMENT, LLC 606,298$6,760,0001.01%
Virtus ETF Advisers LLC 66,851$745,0000.39%
Newbridge Financial Services Group, Inc. 26,900$300,0000.30%
Avidian Wealth Solutions, LLC 330,000$3,680,0000.28%
Spectrum Wealth Advisory Group, LLC 36,692$422,0000.27%
COWEN AND COMPANY, LLC 129,200$1,441,0000.24%
Cormorant Asset Management, LP 500,000$5,575,0000.21%
SYMMETRY PEAK MANAGEMENT LLC 27,500$307,0000.20%
Aristides Capital LLC 24,302$271,0000.19%
View complete list of SORRENTO THERAPEUTICS INC shareholders